Visby Medical Receives FDA Clearance for First Multi-Virus Home PCR
SAN JOSE, California, July 2, 2026 Visby Medical has received U.S. Food and Drug Administration (FDA) clearance for the...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SAN JOSE, California, July 2, 2026 Visby Medical has received U.S. Food and Drug Administration (FDA) clearance for the...
MILFORD, Mass., April 8, 2026 Waters Corporation has announced U.S. FDA clearance for its Onclarityâ„¢ HPV Self-Collection Kit, enabling...
